StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$1.89−0.05 (-2.58%)

Close on Nov 16, 2026Market cap $18.22MP/E –Yield –

Edesa Biotech operating margin

Operating margin is operating income as a percentage of revenue.

Edesa Biotech's operating margin for the twelve months ending Jun 30, 2021 was -4041457.2%. For fiscal 2020 it was -1946.7%, against -2397.1% the year before. The highest annual figure on record is -386.0% in fiscal 2016.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2020Sep 30, 2020-1946.7%+450.4
FY2018Sep 30, 2018-2397.1%−108.5
FY2017Sep 30, 2017-2288.6%−1902.6
FY2016Sep 30, 2016-386.0%+1150.7
FY2014Aug 31, 2014-1536.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2020CQ3 2020Sep 30, 2020-402094.8%−138024.0
Q3 FY2020CQ2 2020Jun 30, 2020-1607.9%+578.2
Q2 FY2020CQ1 2020Mar 31, 2020-1372.0%+726.1
Q1 FY2020CQ4 2019Dec 31, 2019-1025.7%+5758.5
Q3 FY2019CQ2 2019Jun 30, 2019-264070.8%−216539.7
Q4 FY2018CQ3 2018Sep 30, 2018-2186.1%+4114.4
Q2 FY2018CQ1 2018Mar 31, 2018-2098.1%−277.1
Q1 FY2018CQ4 2017Dec 31, 2017-6784.2%−5787.1
Q4 FY2017CQ3 2017Sep 30, 2017-47531.1%−47054.3
Q3 FY2017CQ2 2017Jun 30, 2017-6300.5%–
Q2 FY2017CQ1 2017Mar 31, 2017-1821.0%–
Q1 FY2017CQ4 2016Dec 31, 2016-997.1%–
Q4 FY2016CQ3 2016Sep 30, 2016-476.8%–

More Edesa Biotech figures

See a number that looks wrong?